7,25-dihydroxycholesterol has been researched along with MS (Multiple Sclerosis) in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Clottu, AS; Du Pasquier, R; Mathias, A; Pot, C; Sailer, AW; Schluep, M; Seebach, JD | 1 |
1 other study(ies) available for 7,25-dihydroxycholesterol and MS (Multiple Sclerosis)
Article | Year |
---|---|
EBI2 Expression and Function: Robust in Memory Lymphocytes and Increased by Natalizumab in Multiple Sclerosis.
Topics: Adult; CD11 Antigens; CD4-Positive T-Lymphocytes; Cell Movement; Humans; Hydroxycholesterols; Immunologic Memory; Multiple Sclerosis; Natalizumab; Receptors, G-Protein-Coupled | 2017 |